Suzhou CureMed Biopharma

Suzhou CureMed Biopharma is a biotechnology company focused on the development of innovative mRNA therapeutics and advanced delivery systems. Based in Suzhou, China, the company leverages its proprietary lipid nanoparticle (LNP) technology to enable precise and efficient delivery of genetic medicines. CureMed's research and development efforts are directed toward treating rare diseases, cancers, and infectious conditions through both in vivo and ex vivo applications. The company was co-founded by distinguished scientists, including members of the National Academy of Sciences, to bridge the gap between cutting-edge RNA research and clinical application.